Bright Minds Biosciences Inc. (CSE:DRUG)
Canada flag Canada · Delayed Price · Currency is CAD
38.27
+0.47 (1.24%)
Jun 6, 2025, 3:59 PM EDT

Bright Minds Biosciences Ratios and Metrics

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019
Market Capitalization
2717828107-
Upgrade
Market Cap Growth
5462.49%-19.09%-71.17%-73.71%--
Upgrade
Enterprise Value
216001985-
Upgrade
Last Close Price
38.271.472.158.5045.20-
Upgrade
PB Ratio
4.861.191.232.675.51-
Upgrade
P/TBV Ratio
4.861.191.232.675.52-
Upgrade
Debt / Equity Ratio
0.000.020.010.01--
Upgrade
Quick Ratio
87.6410.9224.168.0031.125.30
Upgrade
Current Ratio
88.2711.3224.268.1131.385.82
Upgrade
Return on Equity (ROE)
-11.21%-46.18%-86.02%-99.95%-85.94%-124.04%
Upgrade
Return on Assets (ROA)
-10.57%-25.19%-47.45%-57.32%-51.52%-61.70%
Upgrade
Return on Capital (ROIC)
-10.80%-26.53%-51.86%-61.21%-53.54%-76.64%
Upgrade
Earnings Yield
-1.27%-42.70%-90.90%-53.20%-8.09%-
Upgrade
Buyback Yield / Dilution
-39.99%-15.87%-50.58%-37.64%-148.42%-74.24%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.